Science Exchange Stories: Pat Corsino from Nuovo Biologics

antiviral

Our user Pat Corsino, a R&D Manager at Nuovo Biologics, is studying the mechanism of action behind their antiviral and oncology technologies. I spoke with him about life and efficiency at an early-stage biotech, check out his advice about being proactive at a small biotech! Q: What does Nuovo Biologics do? Pat: We’re a small […]

Read More…

Reproducibility through peer review

rank-higher

This week we are featuring a guest post on how peer review can improve reproducibility. Check out Aimee Whitcroft from Publons’ thoughts below. There has been much talk over the last few years about the fact that most research, particularly in the medical fields, may not be reproducible – a stunning waste of time and […]

Read More…

Cell Line Authentication and Reproducibility

micro-organisms

Over a third of cell lines used for biomedical research are contaminated or misidentified resulting in wasted resources, unreliable data, and irreproducible results.1 As a result, many journals and funding agencies now require cell line authentication for their studies. Earlier this week, I wrote about our user, Eric Hugo, who did cell line authentication on […]

Read More…

Science Exchange Stories: Eric Hugo, adipose tissue researcher

adipose-tissue

Who knew fat could be so interesting? Eric Hugo did. Eric is an adipose tissue researcher at the University of Cincinnati. His research on adipose cells spans the cellular biology world. From breast cancer to antipsychotic drugs, Eric studies how dopamine receptors on adipose tissue cells respond to things in the body. I spoke with […]

Read More…